Co-culture of DLBCL cell lines with primed T cells in the presence of anti-LAG-3 and anti-TIM-3 induced potent dose-dependent increments in in vitro cell death, suggesting the anti-tumor activity of these antibodies [8]. The gene discussed is HAVCR2; the disease is neoplasm.